Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma.
Seethapathy H, Bates H, Chute DF, Strohbehn I, Strohbehn S, Fadden RM, Reynolds KL, Cohen JV, Sullivan RJ, Sise ME. Seethapathy H, et al. Kidney Med. 2020 Apr 18;2(3):373-375. doi: 10.1016/j.xkme.2020.01.012. eCollection 2020 May-Jun. Kidney Med. 2020. PMID: 32734258 Free PMC article. No abstract available.
Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors.
Seethapathy H, Zhao S, Strohbehn IA, Lee M, Chute DF, Bates H, Molina GE, Zubiri L, Gupta S, Motwani S, Leaf DE, Sullivan RJ, Rahma O, Blumenthal KG, Villani AC, Reynolds KL, Sise ME. Seethapathy H, et al. Kidney Int Rep. 2020 Jul 21;5(10):1700-1705. doi: 10.1016/j.ekir.2020.07.011. eCollection 2020 Oct. Kidney Int Rep. 2020. PMID: 33102962 Free PMC article.
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib.
Seethapathy H, Lee MD, Strohbehn IA, Efe O, Rusibamayila N, Chute DF, Colvin RB, Rosales IA, Fadden RM, Reynolds KL, Sullivan RJ, Kaufman HL, Jhaveri KD, Sise ME. Seethapathy H, et al. Nephrol Dial Transplant. 2022 Feb 25;37(3):507-514. doi: 10.1093/ndt/gfaa372. Nephrol Dial Transplant. 2022. PMID: 33355659 Free PMC article.
Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors.
Chute DF, Zhao S, Strohbehn IA, Rusibamayila N, Seethapathy H, Lee M, Zubiri L, Gupta S, Leaf DE, Rahma O, Drobni ZD, Neilan TG, Reynolds KL, Sise ME. Chute DF, et al. Among authors: seethapathy h. Am J Kidney Dis. 2022 Jan;79(1):134-137. doi: 10.1053/j.ajkd.2021.05.012. Epub 2021 Jun 24. Am J Kidney Dis. 2022. PMID: 34174363 Free PMC article. No abstract available.
Immune checkpoint inhibitor-induced thyroiditis is a risk factor for acute and chronic kidney dysfunction.
Strohbehn IA, Street S, Chute D, Seethapathy H, Lee M, Seethapathy R, Drobni ZD, Rahma O, Neilan TG, Zubiri L, Reynolds K, Sise ME. Strohbehn IA, et al. Among authors: seethapathy h, seethapathy r. Nephrol Dial Transplant. 2021 Dec 31;37(1):187-189. doi: 10.1093/ndt/gfab240. Nephrol Dial Transplant. 2021. PMID: 34383953 Free PMC article. No abstract available.
Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors.
Seethapathy H, Street S, Strohbehn I, Lee M, Zhao SH, Rusibamayila N, Chute DF, Gao X, Michaelson MD, Rahma OE, Choueiri TK, McGregor B, Sonpavde G, Salabao C, Kaymakcalan MD, Wei X, Gupta S, Motwani S, Leaf DE, Reynolds KL, Sise ME. Seethapathy H, et al. Eur J Cancer. 2021 Nov;157:50-58. doi: 10.1016/j.ejca.2021.07.031. Epub 2021 Sep 2. Eur J Cancer. 2021. PMID: 34482189
49 results